|
Options
| ShowHide Related Items >><< - 02/02/23
- Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake
- 01/25/23
- Nordstrom Default Rating downgraded to junk by Fitch
- 01/19/23
- Nordstrom falls 7% to $16.27 after cutting FY22 outlook
- 01/19/23
- Nordstrom cuts FY22 EBIT margin view to 2.8%-3.1% from 4.1%-4.4%
KOLD ProShares UltraShort Bloomberg Natural Gas - 02/01/23
- ProShares UltraShort Bloomberg Natural Gas rises 15.6%
- 01/30/23
- ProShares UltraShort Bloomberg Natural Gas rises 10.6%
- 01/30/23
- ProShares UltraShort Bloomberg Natural Gas rises 10.8%
- 01/26/23
- ProShares UltraShort Bloomberg Natural Gas rises 9.3%
- 01/30/23
- Albemarle launches Ketjen, a wholly owned subsidiary
- 12/13/22
- Albemarle to invest at least $180M in technology park for advanced lithium
- 11/15/22
- Albemarle names Sean O'Hollaren as chief external affairs officer
- 10/31/22
- Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed
- 01/25/23
- AT&T says outlook 'conservative' given economic uncertainty
- 01/25/23
- AT&T says ARPU growth continuing to come in ahead of expectations
- 01/25/23
- AT&T expects 'challenging' macroeconomic environment near term
- 01/25/23
- AT&T expects profit growth to continue in 2023
- 01/31/23
- C3.ai rises 25.2%
- 01/31/23
- C3.ai rises 18.8%
- 01/31/23
- C3.ai rises 12.6%
- 01/27/23
- C3.ai rises 14.4%
- 12/22/22
- Bausch Health' acne lotion included in drug plans of four Canadian provinces
- 12/16/22
- Bausch Health falls -8.5%
- 12/02/22
- Bausch Health wins Bryhali, Duobrii patent infringement case
- 12/02/22
- Bausch Health wins DUOBRII, BRYHALI patent infringement case
- 02/01/23
- Barrick Gold hosts North Mara site visit for human rights NGO
- 01/31/23
- Barrick Gold makes initial $3M payment to Balochistan government for Reko Diq
- 01/25/23
- Barrick Gold says Tanzania gold mines produce 547,000 ounces in 2022
- 01/17/23
- Barrick Gold reports preliminary Q4 gold production 1% lower than 4.2M ozs
- 02/01/23
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 02/01/23
- Meta says 2023 will be 'a year of efficiency'
- 02/01/23
- Meta Platforms announces $40B increase in share repurchase authorization
- 02/01/23
- Meta Platforms reports FoA and RL segment restructuring charges
BKLN Invesco Senior Loan ETF - 07:55 Today William Blair
- Nordstrom performance 'begs for an activist role,' says William Blair
- 06:23 Today Gordon Haskett
- Nordstrom upgraded to Hold from Reduce at Gordon Haskett
- 01/30/23 Goldman Sachs
- Nordstrom initiated with a Neutral at Goldman Sachs
- 01/20/23 Deutsche Bank
- Nordstrom price target lowered to $17 from $21 at Deutsche Bank
KOLD ProShares UltraShort Bloomberg Natural Gas - 01/31/23 Credit Suisse
- Albemarle price target raised to $240 from $200 at Credit Suisse
- 01/26/23 Mizuho
- Albemarle price target raised to $325 from $300 at Mizuho
- 01/26/23 Piper Sandler
- Albemarle initiated with Overweight, $310 target at Piper Sandler
- 01/25/23 Piper Sandler
- Albemarle initiated with an Overweight at Piper Sandler
- 01/26/23 Cowen
- AT&T price target raised to $25 from $24 at Cowen
- 01/24/23 Citi
- AT&T price target raised to $22 from $20 at Citi
- 01/13/23 Truist
- American Tower price target lowered to $275 from $325 at Truist
- 01/10/23 Citi
- Citi adds AT&T, Equinix to 'Positive Catalyst Watch List'
- 02/02/23 DA Davidson
- C3.ai initiated with a Buy at DA Davidson
- 12/08/22 Morgan Stanley
- C3.ai price target lowered to $12 from $13 at Morgan Stanley
- 12/08/22 Piper Sandler
- C3.ai price target lowered to $13 from $14 at Piper Sandler
- 12/08/22 Deutsche Bank
- C3.ai price target lowered to $11 from $13 at Deutsche Bank
- 11/18/22 BofA
- Generic guidance for Bausch Health's Xifaxan 'not a surprise,' says BofA
- 11/17/22 Evercore ISI
- FDA made 'key change' to guidance on generic Xifaxan, says Evercore ISI
- 10/20/22 Jefferies
- Bausch Health assumed with a Hold at Jefferies
- 09/09/22 Piper Sandler
- Bausch Health price target lowered to $6 from $7 at Piper Sandler
- 01/30/23 Barclays
- Barrick Gold price target raised to $26 from $23 at Barclays
- 01/13/23 National Bank
- Barrick Gold price target raised to C$30 from C$25 at National Bank
- 11/29/22 National Bank
- Barrick Gold price target raised to C$25 from C$24 at National Bank
- 11/21/22 RBC Capital
- Barrick Gold price target lowered to $20 from $27 at RBC Capital
- 08:48 Today DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 05:48 Today HSBC
- Meta Platforms downgraded to Reduce from Hold at HSBC
- 05:13 Today DZ Bank
- Meta Platforms upgraded to Hold from Sell at DZ Bank
- 02/02/23 Deutsche Bank
- Meta Platforms price target raised to $200 from $125 at Deutsche Bank
- 01/19/23
- Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60
- 11/22/22
- Nordstrom backs FY22 adjusted EPS view $2.30-$2.60, consensus $2.34
- 11/22/22
- Nordstrom reports Q3 adjusted EPS 20c, consensus 14c
- 11/22/22
- Notable companies reporting after market close
- 01/23/23
- Albemarle targets 5-year net sales CAGR 19%-21% by 2027
- 01/23/23
- Albemarle raises FY22 EPS view to $21.65-$22.05, consensus $21.03
- 01/23/23
- Albemarle reports preliminary Q4 adjusted EPS $8.35-$8.75, consensus $7.66
- 01/23/23
- Albemarle sees FY23 adjusted EPS $26-$33, consensus $28.08
- 01/25/23
- AT&T sees FY23 adjusted EPS $2.35-$2.45, consensus $2.56
- 01/25/23
- AT&T reports Q4 adjusted EPS 61c, consensus 57c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 01/24/23
- Notable companies reporting before tomorrow's open
- 12/07/22
- C3.ai backs FY23 revenue view of $255M-$270M, consensus $260.8M
- 12/07/22
- C3.ai sees Q3 revenue $63.0M-$65.0M, consensus $66.8M
- 12/07/22
- C3.ai reports Q2 EPS (11c), consensus (16c)
- 08/31/22
- C3.ai cuts FY23 revenue view to $255M-$270M from $308M-$316M
- 11/03/22
- Bausch Health cuts FY22 revenue view to $8.0B-$8.17B from $8.05B-$8.22B
- 11/03/22
- Bausch Health reports Q3 adjusted EBITDA $766M vs. $885M y/y
- 08/09/22
- Bausch Health lowers FY22 revenue view to $8.05B-$8.22B from $8.25B-$8.40B
- 08/09/22
- Bausch Health reports Q2 GAAP EPS (40c), consensus 89c
- 11/03/22
- Barrick Gold reports Q3 adjusted EPS 13c, consensus 31c
- 08/08/22
- Barrick Gold reports Q2 adjusted EPS 24c, consensus 31c
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 02/02/23
- Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports
- 09/20/22
- Nordstrom 'back on takeover target list' after poison pill filing
- 10/31/22
- EU looks to resolve EV subsidy dispute with the U.S , Bloomberg says
- 01/12/23
- DirecTV lays off hundreds of employees, Deadline reports
- 12/26/22
- AT&T to build broadband services outside its current markets, WSJ reports
- 12/20/22
- YouTube discussed paying $2.5B a year for NFL Sunday Ticket games, NYT says
- 12/20/22
- FCC partisan deadlock shields wireless companies from $200M fine, WSJ reports
- 08/22/22
- Bausch Health taps advisers to help it map out future, WSJ reports
- 10/15/22
- BHP among mining stocks with bright long-term outlook, Barron's says
- 02/02/23
- FTC denies Meta request to bar Khan from antitrust case, Bloomberg says
- 02/01/23
- GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports
- 02/01/23
- Meta wins approval over FTC to acquire Within Unlimited, Bloomberg says
- 02/01/23
- Meta debates on whether to share Reel money with creators, Information reports
- 09:35 Today
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08:58 Today
- Fly Intel: Pre-market Movers
- 01/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/20/23
- What You Missed On Wall Street This Morning
- 10/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/25/23
- What You Missed On Wall Street On Wednesday
- 01/25/23
- What You Missed On Wall Street This Morning
- 01/25/23
- Fly Intel: Pre-market Movers
- 01/14/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/08/22
- What You Missed On Wall Street On Thursday
- 12/08/22
- What You Missed On Wall Street This Morning
- 09/02/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/01/22
- Fly Intel: Pre-market Movers
- 08/09/22
- What You Missed On Wall Street On Tuesday
- 08/09/22
- What You Missed On Wall Street This Morning
- 09:35 Today
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 02/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
BKLN Invesco Senior Loan ETF - 01/25/23
- Largest borrow rate increases among liquid names
- 11/29/22
- Unusually active option classes on open November 29th
- 10/19/22
- Largest borrow rate increases among liquid names
- 10/18/22
- Largest borrow rate increases among liquid names
- 02/01/23
- Unusually active option classes on open February 1st
- 01/27/23
- Unusually active option classes on open January 27th
- 01/20/23
- Unusually active option classes on open January 20th
- 01/05/23
- Nordstrom call volume above normal and directionally bullish
KOLD ProShares UltraShort Bloomberg Natural Gas - 01/26/23
- Unusually active option classes on open January 26th
- 01/20/23
- Largest borrow rate increases among liquid names
- 01/12/23
- Largest borrow rate increases among liquid names
- 01/03/23
- Unusually active option classes on open January 3rd
- 12/27/22
- Albemarle call volume above normal and directionally bullish
- 12/06/22
- Albemarle call volume above normal and directionally bullish
- 11/25/22
- Unusually active option classes on open November 25th
- 11/15/22
- Albemarle put volume heavy and directionally bearish
- 01/25/23
- Early notable gainers among liquid option names on January 25th
- 01/17/23
- AT&T call volume above normal and directionally bullish
- 01/09/23
- Unusually active option classes on open January 9th
- 01/04/23
- Unusually active option classes on open January 4th
- 02/02/23
- Unusually active option classes on open February 2nd
- 02/01/23
- Unusually active option classes on open February 1st
- 01/31/23
- C3 AI call volume above normal and directionally bullish
- 01/31/23
- Unusually active option classes on open January 31st
- 01/23/23
- Unusually active option classes on open January 23rd
- 12/22/22
- Unusually active option classes on open December 22nd
- 09/19/22
- Unusually active option classes on open September 19th
- 09/12/22
- Unusually active option classes on open September 12th
- 01/25/23
- Bausch Health put volume heavy and directionally bearish
- 01/20/23
- Bausch Health put volume heavy and directionally bearish
- 01/18/23
- Bausch Health put volume heavy and directionally bearish
- 01/09/23
- Bausch Health call volume above normal and directionally bullish
- 01/19/23
- Barrick Gold call volume above normal and directionally bullish
- 12/27/22
- Barrick Gold call volume above normal and directionally bullish
- 12/13/22
- Unusually active option classes on open December 13th
- 12/07/22
- Barrick Gold call volume above normal and directionally bullish
- 08:55 Today
- Notable open interest changes for February 3rd
- 07:35 Today
- Unusual call flow in option market yesterday
- 02/02/23
- Earnings season driving record option volume
- 02/02/23
- Early notable gainers among liquid option names on February 2nd
|
|
Recommendations
|
BMO Capital analyst Joel… ShowHide Related Items >><< - 12/05/22
- Ekso Bionics announces acquisition of business unit from Parker Hannifin
- 10/26/22
- Parker-Hannifin appoints Jennifer Parmentier as CEO, Andrew Ros as COO
- 09/20/22
- Parker-Hannifin releases 2022 Sustainability Report
- 09/19/22
- Parker-Hannifin completes sale of Aircraft Wheel, Brake Division to Kaman
- 09:25 Today Deutsche Bank
- Parker-Hannifin price target raised to $322 from $307 at Deutsche Bank
- 06:56 Today Baird
- Parker-Hannifin price target raised to $403 from $385 at Baird
- 02/02/23 Baird
- Parker-Hannifin price target raised to $403 from $385 at Baird
- 01/13/23 Mizuho
- Parker-Hannifin price target raised to $310 from $300 at Mizuho
- 02/02/23
- Parker-Hannifin sees FY23 adjusted EPS $19.20-$19.70, consensus $19.11
- 02/02/23
- Parker-Hannifin reports Q2 adjusted EPS $4.76, consensus $4.46
- 11/03/22
- Parker-Hannifin now sees FY23 adjusted EPS $18.60-$19.30, consensus $18.54
- 11/03/22
- Parker-Hannifin reports Q1 adjusted EPS $4.74, consensus $4.16
- 01/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/14/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Hot Stocks
| ShowHide Related Items >><< RSLS ReShape Lifesciences - 09:32 Today
- ReShape Lifesciences Inc trading halted, volatility trading pause
- 01/03/23
- ReShape Lifesciences Inc trading resumes
- 01/03/23
- ReShape Lifesciences Inc trading halted, volatility trading pause
- 12/29/22
- ReShape Lifesciences Inc trading resumes
RSLS ReShape Lifesciences - 08/17/22 Alliance Global Partners
- ReShape Lifesciences price target lowered to $1.75 from $4.65 at Alliance Global Partners
- 05/26/22 Alliance Global Partners
- ReShape price target lowered to $4.65 from $5.50 at Alliance Global
- 03/29/22 Alliance Global Partners
- ReShape Lifesciences target cut to $5.50 from $10.25 at Alliance Global Partners
- 03/29/22 Maxim
- ReShape Lifesciences price target lowered to $4 from $8 at Maxim
RSLS ReShape Lifesciences - 11/14/22
- ReShape Lifesciences reports Q3 revenue $2.8M, consensus $3.62M
|
|
Recommendations
| ShowHide Related Items >><< - 02/02/23
- Microchip sees FY23 capital expenditures $525M-$545M
- 02/02/23
- Microchip boosts dividend 41.5% to 35.8c per share
- 01/19/23
- Microchip announces hybrid power drive module
- 01/17/23
- Microchip launches first COTS rad-tolerant power device
- 09:06 Today Needham
- Microchip price target raised to $110 from $82 at Needham
- 08:00 Today Susquehanna
- Microchip price target raised to $100 from $85 at Susquehanna
- 07:46 Today B. Riley
- Microchip price target raised to $106 from $86 at B. Riley
- 06:58 Today Citi
- Microchip price target raised to $85 from $74 at Citi
- 02/02/23
- Microchip sees Q4 EPS $1.61- $1.63, consensus $1.58
- 02/02/23
- Microchip reports Q3 EPS $1.56, consensus $1.55
- 02/02/23
- Notable companies reporting after market close
- 11/28/22
- Microchip back Q3 EPS view $1.54-$1.56, consensus $1.58
- 01/04/23
- China pauses chip industry investments as COVID resurges, Bloomberg reports
- 12/13/22
- China files WTO complaint targeting prior U.S. chip sanctions, FT reports
- 10/06/22
- Restrictions on China chipmakers won't target SK Hynix and Samsung, Reuters says
- 08/10/22
- Chip makers now expect demand slowdown beyond PCs, WSJ reports
- 02/02/23
- Fly Intel: After-Hours Movers
- 01/04/23
- What You Missed On Wall Street On Wednesday
- 01/04/23
- What You Missed On Wall Street This Morning
- 11/03/22
- Fly Intel: After-Hours Movers
- 01/24/23
- Microchip put volume heavy and directionally bearish
- 01/23/23
- Microchip put volume heavy and directionally bearish
- 01/05/23
- Microchip put volume heavy and directionally bearish
- 11/16/22
- Microchip put volume heavy and directionally bearish
|
|
Hot Stocks
| ShowHide Related Items >><< - 11/21/22
- Gaucho Group regains compliance with Nasdaq listing rules
- 11/03/22
- Gaucho Group board approves 1-for-12 reverse stock split
- 11/02/22
- Gaucho Group's Algodon Wine Estates receives approval to drill water well
- 10/31/22
- Gaucho Group's Algodon Fine Wines to develop DTC ecommerce platform
|
|
On The Fly
| ShowHide Related Items >><< - 02/02/23
- Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake
- 01/25/23
- Nordstrom Default Rating downgraded to junk by Fitch
- 01/19/23
- Nordstrom falls 7% to $16.27 after cutting FY22 outlook
- 01/19/23
- Nordstrom cuts FY22 EBIT margin view to 2.8%-3.1% from 4.1%-4.4%
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 09/15/22
- PayrHealth announces collaboration with Cardinal Health
- 01/24/23
- International Paper to sell ownership in Ilim joint venture for $484M
- $209.24 /
-5.265 (-2.45%) - 02/01/23
- Boeing awarded $1.62B Air Force contract
- 02/01/23
- Atlas Air takes delivery of final 747 to be produced by Boeing
- 01/31/23
- Atlas Air takes delivery of Boeing's final 747 production aircraft
- 01/30/23
- Boeing awarded U.S. Air Force contract for 15 KC-46A tankers
- 01/17/23
- Lightspeed announces reorganization, 10% workforce reduction
- 12/30/22
- Lightspeed announces Saintil to step down from board of directors
- 12/29/22
- Lightspeed rises 7.8%
- 12/06/22
- Lightspeed names Kady Srinivasan as Chief Marketing Officer
- 11/07/22
- Synaptics senior VP McFarland sells 12,299 common shares
- 10/28/22
- Synaptics acquires Emza Visual Sense, extends leadership position
- $188.78 /
+35.675 (+23.30%) - 02/01/23
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 02/01/23
- Meta says 2023 will be 'a year of efficiency'
- 02/01/23
- Meta Platforms announces $40B increase in share repurchase authorization
- 02/01/23
- Meta Platforms reports FoA and RL segment restructuring charges
- 02/02/23
- Ford sees FY23 capital expenditures $8B-$9B
- 02/02/23
- Ford down 6% after Q4 earnings report
- 02/02/23
- Ford declares regular Q1 dividend of 15c, supplemental dividend of 65c
- 02/02/23
- Ford reports January U.S. sales up 2% to 146,356 vehicles
DAWN Day One Biopharmaceuticals - 01/08/23
- Day One announces top line data from pivotal Phase 2 FIREFLY-1 trial
- 10/17/22
- Day One Biopharmaceuticals announces CRADA with NCI for tovorafenib
- 09/12/22
- Day One Biopharmaceuticals appoints Nicholson as chairman
- 12/06/22
- Herbalife Nutrition falls -19.5%
- 12/06/22
- Herbalife Nutrition falls -16.6%
- 12/06/22
- Herbalife Nutrition falls -15.0%
- 12/05/22
- Herbalife Nutrition falls 10% to $15.70 after offering $250M in convertible debt
AGIO Agios Pharmaceuticals - 12/11/22
- Agios Pharmaceuticals presents updated PYRUKYND long-term extension data
- 12/11/22
- Agios Pharmaceuticals presents updated PYRUKYND data
- 12/06/22
- Agios Pharmaceuticals appoints Tsveta Milanova as CCO
- 11/03/22
- Agios Pharmaceuticals expects cash to fund operations through catalysts
- $107.96 /
-2.045 (-1.86%) - 01/09/23
- Xenon Pharmaceuticals outlines key milestone opportunities for 2023
- 01/09/23
- Voyager, Neurocrine enter collaboration to advance multiple gene therapies
- 12/22/22
- Neurocrine: FDA accepts sNDA for valbenazine
- 12/06/22
- Neurocrine announces NBI-827104 did not meet its primary endpoint in Phase 2
- 09/26/22
- H.B. Fuller names Celeste Mastin as new CEO
- 09/21/22
- H.B. Fuller narrows FY22 adjusted EBITDA view to $540M-$550M from $530M-$550M
- 02/02/23
- Enphase Energy demonstrates bidirectional EV charger technology
- 01/30/23
- Enphase Energy expands solar deployments in Brazil
- 01/26/23
- Enphase, Enerix to expand solar, battery storage product offerings in Europe
- 01/17/23
- Enphase Energy expands IQ8 microinveter deployments in the Netherlands
- 01/17/23
- Privia Health announces launches of ACOs in Delaware and North Carolina
- 12/05/22
- NeoGenomics names Jeffrey Sherman as new CFO
- 11/15/22
- Privia Health announces Butler resigned from board of directors
- 10/03/22
- Director of Privia Health sold 80,853 shares of company stock
- 07:55 Today William Blair
- Nordstrom performance 'begs for an activist role,' says William Blair
- 06:23 Today Gordon Haskett
- Nordstrom upgraded to Hold from Reduce at Gordon Haskett
- 01/30/23 Goldman Sachs
- Nordstrom initiated with a Neutral at Goldman Sachs
- 01/20/23 Deutsche Bank
- Nordstrom price target lowered to $17 from $21 at Deutsche Bank
- 06:29 Today Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 05:09 Today Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 11/22/22 Credit Suisse
- Cardinal Health price target raised to $79 from $64 at Credit Suisse
- 06:46 Today UBS
- International Paper upgraded to Neutral from Sell at UBS
- 06:37 Today UBS
- International Paper upgraded to Neutral from Sell at UBS
- 02/02/23 Argus
- International Paper price target raised to $50 from $43 at Argus
- 02/01/23 Truist
- International Paper price target raised to $38 from $30 at Truist
- $209.24 /
-5.265 (-2.45%) - 05:08 Today RBC Capital
- Boeing downgraded to Sector Perform from Outperform at RBC Capital
- 01/30/23 Jefferies
- Boeing price target raised to $250 from $240 at Jefferies
- 01/26/23 Morgan Stanley
- Boeing remains a 'show me story,' says Morgan Stanley
- 01/12/23 Credit Suisse
- Credit Suisse upgrades Boeing to Neutral, raises price target to $200
- 07:15 Today Credit Suisse
- Lightspeed downgraded to Neutral from Outperform at Credit Suisse
- 02/02/23 CIBC
- Lightspeed downgraded to Neutral from Outperformer at CIBC
- 01/25/23 BofA
- Lightspeed initiated with a Neutral at BofA
- 01/25/23 BofA
- Lightspeed initiated with a Neutral at BofA
- 08:21 Today Craig-Hallum
- Synaptics price target raised to $150 from $120 at Craig-Hallum
- 08:12 Today Susquehanna
- Synaptics price target raised to $145 from $115
- 07:50 Today Oppenheimer
- Synaptics downgraded to Perform from Outperform at Oppenheimer
- 07:32 Today Cowen
- Synaptics price target raised to $150 from $100 at Cowen
- $188.78 /
+35.675 (+23.30%) - 08:48 Today DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 05:48 Today HSBC
- Meta Platforms downgraded to Reduce from Hold at HSBC
- 05:13 Today DZ Bank
- Meta Platforms upgraded to Hold from Sell at DZ Bank
- 02/02/23 Deutsche Bank
- Meta Platforms price target raised to $200 from $125 at Deutsche Bank
- 07:47 Today Benchmark
- Ford price target lowered to $19 from $21 at Benchmark
- 06:37 Today Deutsche Bank
- Deutsche downgrades Ford to Sell on 'meaningful' earnings risk
- 06:04 Today Deutsche Bank
- Ford downgraded to Sell from Hold at Deutsche Bank
- 01/25/23 JPMorgan
- Ford price target lowered to $15 from $16 at JPMorgan
DAWN Day One Biopharmaceuticals - 02/02/23 Oppenheimer
- Day One Biopharmaceuticals initiated with a Perform at Oppenheimer
- 01/09/23 H.C. Wainwright
- Day One Biopharmaceuticals price target raised to $45 from $35 at H.C. Wainwright
- 01/08/23 Piper Sandler
- Day One Biopharmaceuticals price target raised to $45 from $40 at Piper Sandler
- 12/15/22 H.C. Wainwright
- Day One Biopharmaceuticals initiated with a Buy at H.C. Wainwright
- 07:33 Today BofA
- Herbalife Nutrition initiated with an Underperform at BofA
- 11/01/22 B. Riley
- Herbalife Nutrition price target lowered to $31 from $38 at B. Riley
- 11/01/22 Citi
- Herbalife Nutrition price target lowered to $26 from $30 at Citi
- 10/05/22 Citi
- Herbalife Nutrition price target lowered to $30 from $36 at Citi
AGIO Agios Pharmaceuticals - 04:25 Today Piper Sandler
- Agios Pharmaceuticals initiated with an Overweight at Piper Sandler
- 11/17/22 Goldman Sachs
- Agios Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
- 07/27/22 SVB Securities
- Agios Pharmaceuticals upgraded to Outperform from Market Perform at SVB Securities
- 02/25/22 RBC Capital
- Agios Pharmaceuticals price target raised to $67 from $61 at RBC Capital
- $107.96 /
-2.045 (-1.86%) - 05:54 Today Morgan Stanley
- Neurocrine upgraded to Overweight from Equal Weight at Morgan Stanley
- 12/13/22 RBC Capital
- Neurocrine CAH data appears pushed back, says RBC Capital
- 11/14/22 Evercore ISI
- Neurocrine downgraded to In Line from Outperform at Evercore ISI
- 11/02/22 BMO Capital
- Neurocrine price target raised to $101 from $78 at BMO Capital
- 05:58 Today Citi
- H.B. Fuller upgraded to Buy from Neutral at Citi
- 01/23/23 Citi
- H.B. Fuller price target raised to $72 from $65 at Citi
- 01/20/23 Deutsche Bank
- H.B. Fuller price target raised to $78 from $72 at Deutsche Bank
- 01/20/23 Baird
- H.B. Fuller price target lowered to $80 from $85 at Baird
- 07:53 Today Janney Montgomery Scott
- Enphase Energy initiated with a Neutral at Janney Montgomery Scott
- 02/01/23 Barclays
- SolarEdge price target lowered to $392 from $396 at Barclays
- 02/01/23 Barclays
- Enphase Energy price target lowered to $251 from $311 at Barclays
- 01/30/23 Goldman Sachs
- Enphase Energy price target lowered to $327 from $379 at Goldman Sachs
- 04:26 Today Goldman Sachs
- Privia Health initiated with a Buy at Goldman Sachs
- 01/17/23 Piper Sandler
- Piper Sandler would be a buyer of Privia Health following CMS data
- 01/09/23 BTIG
- Privia Health price target lowered to $40 from $45 at BTIG
- 12/08/22 Stifel
- Privia Health initiated with a Buy at Stifel
- 01/19/23
- Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60
- 11/22/22
- Nordstrom backs FY22 adjusted EPS view $2.30-$2.60, consensus $2.34
- 11/22/22
- Nordstrom reports Q3 adjusted EPS 20c, consensus 14c
- 11/22/22
- Notable companies reporting after market close
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 02/01/23
- Notable companies reporting before tomorrow's open
- 01/31/23
- International Paper reports Q4 adjusted EPS 87c, consensus 69c
- 10/27/22
- International Paper reports Q3 adjusted EPS $1.01, consensus $1.21
- $209.24 /
-5.265 (-2.45%) - 01/25/23
- Boeing reports Q4 core EPS ($1.75), consensus 26c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 01/24/23
- Notable companies reporting before tomorrow's open
- 10/26/22
- Boeing reports Q3 core EPS ($6.18), consensus 2c
- 02/02/23
- Lightspeed sees FY23 revenue at low end of $730M-$740M, consensus $733.15M
- 02/02/23
- Lightspeed reports Q3 adjusted EPS 0c, consensus (5c)
- 11/03/22
- Lightspeed sees Q3 revenue at constant currency $189M-$194M, consensus $200.48M
- 11/03/22
- Lightspeed reports Q3 adjusted EPS (5c), consensus (7c)
- 02/02/23
- Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M
- 02/02/23
- Synaptics reports Q2 EPS $2.20, consensus $2.34
- 11/03/22
- Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M
- 11/03/22
- Synaptics reports Q1 EPS $3.52, consensus $3.31
- $188.78 /
+35.675 (+23.30%) - 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 02/02/23
- Notable companies reporting after market close
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
DAWN Day One Biopharmaceuticals - 11/07/22
- Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c)
- 08/04/22
- Day One Biopharmaceuticals reports Q2 EPS (60c), consensus (49c)
- 10/31/22
- Herbalife Nutrition reports Q3 EPS 91c, consensus 74c
AGIO Agios Pharmaceuticals - 11/03/22
- Agios Pharmaceuticals reports Q3 EPS ($1.49), consensus ($1.76)
- 08/04/22
- Agios Pharmaceuticals reports Q2 EPS ($1.68), consensus ($1.75)
- $107.96 /
-2.045 (-1.86%) - 11/01/22
- Neurocrine reports Q3 non-GAAP EPS $1.08, consensus 79c
- 08/04/22
- Neurocrine reports Q2 non-GAAP EPS 84c, consensus 15c
- 01/18/23
- H.B. Fuller sees FY23 adjusted EPS $4.15-$4.55, consensus $4.63
- 01/18/23
- H.B. Fuller reports Q4 adjusted EPS $1.04, consensus $1.24
- 09/21/22
- H.B. Fuller sees Q4EPS $1.15-$1.30, consensus $1.28
- 09/21/22
- H.B. Fuller reports Q3 EPS $1.06, consensus $1.04
- 10/25/22
- Enphase Energy sees Q4 revenue $680M-$720M, consensus $660.21M
- 10/25/22
- Enphase Energy reports Q3 EPS $1.25, consensus $1.08
- 10/25/22
- Notable companies reporting after market close
- 11/10/22
- Privia Health raises FY22 revenue view to $1.3B-$1.335B from $1.225B-$1.3B
- 11/10/22
- Privia Health reports Q3 adjusted EPS 13c, consensus 0c
- 08/11/22
- Privia Health sees 2022 revenue at high end of $1.225B-$1.3B
- 08/11/22
- Privia Health reports Q2 adjusted EPS 13c vs. 9c last year.
|
|
Recommendations
| ShowHide Related Items >><< - $107.71 /
+7.275 (+7.24%) - 02/02/23
- Alphabet says started bringing revenue sharing to YouTube Shorts
- 02/02/23
- Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year
- 02/02/23
- Alphabet taking actions to optimize global office space
- 02/01/23
- 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14
- $107.71 /
+7.275 (+7.24%) - 08:48 Today DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 08:13 Today Roth MKM
- Alphabet price target raised to $126 from $120 at Roth MKM
- 07:36 Today JPMorgan
- Alphabet price target raised to $118 from $115 at JPMorgan
- 07:28 Today Credit Suisse
- Alphabet price target lowered to $136 from $145 at Credit Suisse
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Democratic senator joins calls to ban TikTok, WSJ reports
- 02/01/23
- GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports
- 02/01/23
- Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports
- 01/31/23
- Reels sharing revenue with creators hotly debated within Meta, Information says
- $107.71 /
+7.275 (+7.24%) - 08:58 Today
- Fly Intel: Pre-market Movers
- 02/02/23
- Fly Intel: After-Hours Movers
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- $107.71 /
+7.275 (+7.24%) - 08:55 Today
- Notable open interest changes for February 3rd
- 02/02/23
- Alphabet Class A options imply 5.4% move in share price post-earnings
- 02/02/23
- Early notable gainers among liquid option names on February 2nd
- 01/20/23
- Early notable gainers among liquid option names on January 20th
|
|
Hot Stocks
| ShowHide Related Items >><< RSLS ReShape Lifesciences - 01/03/23
- ReShape Lifesciences Inc trading resumes
- 01/03/23
- ReShape Lifesciences Inc trading halted, volatility trading pause
- 12/29/22
- ReShape Lifesciences Inc trading resumes
- 12/29/22
- ReShape Lifesciences Inc trading halted, volatility trading pause
RSLS ReShape Lifesciences - 08/17/22 Alliance Global Partners
- ReShape Lifesciences price target lowered to $1.75 from $4.65 at Alliance Global Partners
- 05/26/22 Alliance Global Partners
- ReShape price target lowered to $4.65 from $5.50 at Alliance Global
- 03/29/22 Alliance Global Partners
- ReShape Lifesciences target cut to $5.50 from $10.25 at Alliance Global Partners
- 03/29/22 Maxim
- ReShape Lifesciences price target lowered to $4 from $8 at Maxim
RSLS ReShape Lifesciences - 11/14/22
- ReShape Lifesciences reports Q3 revenue $2.8M, consensus $3.62M
|
|
Recommendations
|
BMO Capital analyst Joel… ShowHide Related Items >><< - 01/18/23
- Wabash announces 10-year agreement with Ryerson
- 01/10/23
- Wabash signs long-term supply agreement with J.B. Hunt
- 09/26/22
- Wabash announces amendment to asset-backed lending facility
- 09/21/22
- Bollinger Motors, Wabash announce joint development
- 01/06/23 Raymond James
- Wabash price target raised to $27 from $23 at Raymond James
- 12/05/22 Vertical Research
- Wabash downgraded to Hold from Buy at Vertical Research
- 11/22/22 DA Davidson
- Wabash price target raised to $29 from $25 at DA Davidson
- 02/02/23
- Wabash sees FY23 EPS $2.70-$3.00, consensus $2.45
- 02/02/23
- Wabash reports Q4 EPS 84c, consensus 71c
- 10/26/22
- Wabash raises FY22 EPS view to $2.15 from $1.90
- 10/26/22
- Wabash reports Q3 EPS 73c, consensus 57c
- 10/26/22
- Wabash targets 2025 EPS of $3.50, sales of $3.0B
|
|
Hot Stocks
| ShowHide Related Items >><< - 11/14/22
- Green Giant appoints Junaid Ali as CEO of Green Giant LLC
|
